GNRHR

(redirected from Gonadotropin-releasing hormone receptor)
Also found in: Wikipedia.
AcronymDefinition
GNRHRGonadotropin-Releasing Hormone Receptor
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Gonadotropin-releasing hormone receptor gene expression in rat anterior pituitary.
Differential G protein coupling preference of mammalian and nonmammalian gonadotropin-releasing hormone receptors. Mol.
Role of gonadotropin-releasing hormone receptor mutations in patients with a wide spectrum of pubertal delay.
number Gene NM.001034034 GAPDH glyceraldehyde-3-phosphate dehydrogenase U39357 ACTB beta actin BC108088.1 HDAC1 histone deacetylase 1 NM.001009397 GnRHR gonadotropin-releasing hormone receptor U02517 GnRH gonadotropin-releasing hormone X52488 LHB luteinizing hormone beta-subunit X15493 FSHB follicle stimulating hormone beta-subunit NM.001009306 PRL prolactin GenBank acc.
Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev 1997;18(2):180-205.
Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor. Biochem Biophys Res Commun 2005;333(2):568-582.
Steroidogenic factor-1 interacts with a gonadotrope-specific element within the first exon of the human gonadotropin-releasing hormone receptor gene to mediate gonadotrope-specific expression.
Silveira, "Novel mutation in the gonadotropin-releasing hormone receptor (GNRHR) gene in a patient with normosmic isolated hypogonadotropic hypogonadism," Arquivos Brasileiros de Endocrinologia e Metabologia, vol.
A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.
Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism.
Elagolix, an orally administered, short-acting gonadotropin-releasing hormone receptor antagonist, ultimately leads to reduced ovarian production of ovarian sex hormones while on therapy.
Relugolix is an oral, once-daily, small molecule gonadotropin-releasing hormone receptor antagonist that decreases estrogen and progesterone.
Full browser ?